FDA orphan drug designation: treatment of myasthenia gravis
All entries for: Novartis Pharmaceuticals Corporation
December 19, 2025
Novartis Pharmaceuticals Corporation
Orphan Drug Designation
Disease Area: Rare Diseases
FDA orphan drug designation: treatment of myasthenia gravis